scholarly journals Recurrent Urosepsis and Cardiogenic Shock in an Elderly Patient with Pheochromocytoma

2011 ◽  
Vol 2011 ◽  
pp. 1-4 ◽  
Author(s):  
Joan Joo-Ching Khoo ◽  
Vanessa Shu-Chuan Au ◽  
Richard Yuan-Tud Chen

Pheochromocytomas are thought to be uncommon in the elderly. However, the prevalence is likely to be higher than reported, as older patients are less likely to be diagnosed due to absence of classical symptoms of sympathetic overactivity and confounding effects of aging, comorbidities, and medications. We describe a hypertensive elderly patient with incidentally diagnosed pheochromocytoma complicated by recurrent urosepsis, cardiomyopathy, and fatal myocardial infarction. Our case demonstrates that, in older hypertensive patients without classical symptoms, orthostatic hypotension and urinary retention, which are common in the elderly, may indicate catecholamine excess and that the deleterious cardiovascular consequences of catecholamine excess in the elderly are not prevented by pharmacological α- and β-blockade.

2011 ◽  
Vol 78 (4) ◽  
pp. 505-511 ◽  
Author(s):  
Francesco Tomassini ◽  
Andrea Gagnor ◽  
Alessandro Migliardi ◽  
Emanuele Tizzani ◽  
Vincenzo Infantino ◽  
...  

2019 ◽  
Vol 147 (3-4) ◽  
pp. 167-172
Author(s):  
Jadranka Dejanovic ◽  
Igor Ivanov ◽  
Tanja Popov ◽  
Milenko Cankovic ◽  
Aleksandra Vulin ◽  
...  

Introduction/Objective. Population of elderly people is increasing and modern medicine is faced with the problem of large morbidity and mortality from cardiovascular diseases in this age group. Modern treatment strategies have not been sufficiently investigated in the elderly, therefore these people often receive suboptimal treatment. The aim of the study was to evaluate clinical characteristic, cardiac risk factors, management strategies and early outcome in the elderly patient with ST elevated myocardial infarction (STEMI). Methods. This retrospective study included 217 consecutive patients, aged ? 70 years (mean age 77.6 ? 4.9 years, 103 men, 114 women) with STEMI admitted to the Institute of Cardiovascular Diseases of Vojvodina. We have analyzed patients? clinical characteristics, risk factors, left ventricular function and treatment strategies in relation to in-hospital outcome. Results. First clinical symptom was chest pain in 209 (96.3%) of patients. On admission, 35 (16.1%) patients were with severe signs of heart failure (Killip class III?IV). Duration of symptom onset to hospital admission was 14.7 ? 28.6 hours. Out of 217 patients, 168 (77.4%) patients received reperfusion treatment, including primary percutaneous coronary ntervention (PPCI) in 164 (75.6%) patients, and fibrinolytic therapy in 4 (1.8%) patients. Hospital mortality was 26.3% (57 patients). PPCI was univariate predictor of lower in-hospital mortality, whereas multivariate predictors of in-hospital mortality were cardiogenic shock (OR 67.095; 95% CI (6.845?657.646); p < 0.001) and low ejection fraction (OR 0.901; 95% CI (0.853?0.963); p = 0.001). Conclusion. In elederly patients presenting with STEMI, PPCI was asscoiated with lower mortality, whereas cardiogenic shock and lower ejection fraction were independent predictors of worse prognosis after STEMI.


2015 ◽  
Vol 2 (2) ◽  
pp. 33
Author(s):  
Tatjana Ivanković Zrnić

An apparent decline in the birth rate that accompanies the aging population with prolonged life expectancy requires greater investment in the health care of the elderly. It is necessary to identify the conditions that naturally carries the older times, expect a slower recovery in comparison to young people, but do not exclude recovery in treatment.In practice we often encounter indifference and neglect of an elderly patient by the medical staff, the assumption is that this is justified by insufficiently motivated patient.Searching PubMed, PubMed Central, Google Scholar and HINARI, we analyzed how this topic is present in nivioma protects the health and recognizing the importance of personalized care for older patients in the world.The results of many studies indicate that there is a neglect of elderly patients, resulting in poor outcome of care.Requires additional training of staff working with elderly patients to improving attitudes and extreme improve the treatment of these patients.Negative attitudes towards older patients contribute to business dissatisfaction medical staff.


Author(s):  
Fraser Birrell ◽  
Janice O’Connell

In this chapter, we describe how the process of ageing can itself affect the diagnosis and treatment of musculoskeletal conditions. We outline general principles concerning the clinical presentation of rheumatological diseases in older patients, as well as providing specific guidance on the diagnosis and management of the commoner conditions encountered in practice in the United Kingdom.


2007 ◽  
Vol 25 (14) ◽  
pp. 1832-1843 ◽  
Author(s):  
Stuart M. Lichtman ◽  
Hans Wildiers ◽  
Etienne Chatelut ◽  
Christopher Steer ◽  
Daniel Budman ◽  
...  

The elderly comprise the majority of patients with cancer and are the recipients of the greatest amount of chemotherapy. Unfortunately, there is a lack of data to make evidence-based decisions with regard to chemotherapy. This is due to the minimal participation of older patients in clinical trials and that trials have not systematically evaluated chemotherapy. This article reviews the available information with regard to chemotherapy and aging provided by a task force of the International Society of Geriatric Oncology (SIOG). Due to the lack of prospective data, the conclusions and recommendations made are a consensus of the participants. Extrapolation of data from younger to older patients is necessary, particularly to those patients older than 80 years, for which data is almost entirely lacking. The classes of drugs reviewed include alkylators, antimetabolites, anthracyclines, taxanes, camptothecins, and epipodophyllotoxins. Clinical trials need to incorporate an analysis of chemotherapy in terms of the pharmacokinetic and pharmacodynamic effects of aging. In addition, data already accumulated need to be reanalyzed by age to aid in the management of the older cancer patient.


1988 ◽  
Vol 26 (3) ◽  
pp. 9-10

The risk of cardiovascular disease increases with blood pressure at all ages and in both sexes.1 The risk of stroke2 and heart failure is especially high in older hypertensive patients. However, treating raised blood pressure in the elderly poses problems: they are at especial risk from unwanted effects of drugs and from interactions with drugs taken for other diseases; it may be more difficult to ensure treatment is taken regularly; and, as systolic blood pressure rises with age partly because the arterial walls lose elasticity, the definition of hypertension in older patients is less certain. As with mild hypertension in younger patients, the clinical problem is to determine at what level of blood pressure and in which particular patients the benefits from treatment outweigh the disadvantages.3


2013 ◽  
Vol 166 (2) ◽  
pp. 298-305 ◽  
Author(s):  
Akshay Bagai ◽  
Anita Y. Chen ◽  
Tracy Y. Wang ◽  
Karen P. Alexander ◽  
Laine Thomas ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document